Catalog2 refs
Cartalax
BioregulatorsHealing & RecoveryMusculoskeletalResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Body Map
JointsSkin
Overview
Cartalax is a synthetic tripeptide (Ala-Glu-Asp, or AED) from the Khavinson family of short peptide bioregulators, studied as a cartilage and connective-tissue regulator. It belongs to the cytogen class of short peptides, proposed to regulate tissue-specific gene expression in cartilage cells, upregulating chondrogenic genes such as SOX9, type II collagen (COL2) and aggrecan (ACAN).
Primary Uses
Cartilage repair
Chondroprotection
Osteoarthritis models
Extracellular matrix research
Joint and connective tissue support
Osteoarthritis treatment
Osteochondrosis treatment
Osteoporosis treatment
Degenerative joint disease prevention
Post-fracture recovery
Fibroblast activation
Collagen production
Cellular senescence reduction
Cartilage regeneration support
cartilage and joint research
cartilage and joint support
Cartilage regulation
Connective-tissue regulation
Matrix synthesis
Protocol Reference
Dose
2mg/day
Frequency
Once daily (injection); 1-2 capsules 1-2x daily (oral)
Half-life
Short (tripeptide)
Route
Subcutaneous · Oral
Evidence
Preclinical / Emerging (disputed)
Research References· 3
Research Models
HumanIn vitroanimal
Also in Bioregulators